1187.HK
Strong BuyUnloved QualityAI neutralCofoe Medical Technology Co.,Ltd. · Healthcare · China · $913M
HKD 27.32 -2.6% · close 8 Oct · scored 9 Oct
Unloved Quality: Strong and cheap; the market has not turned yet.
Read our full research report on 1187.HK (Jul 2026), freeDoes StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Cofoe Medical makes home and hospital medical devices in China, such as blood-pressure monitors, oxygen concentrators and mobility aids. Management conviction signals are strong: insiders have bought about 12% of the listed H-shares in 90 days, the company has repurchased about 9.6% of them, and forward earnings estimates have risen about 5% in four weeks. The valuation score is high. The case still lacks detail on growth drivers and competitive position, and the business does not benefit from the main macro trends identified.
ABOUT COFOE MEDICAL TECHNOLOGY CO.,LTD.
Read
Cofoe Medical Technology Co.,Ltd. researches, develops, manufactures, and sells medical devices and home healthcare equipment, including wheelchairs, blood pressure monitors, and nursing beds. The company's competitive moat is its strong multi-channel sales network, combining a dominant e-commerce presence in China with extensive offline retail coverage. It is a leading player in China's home medical device market, known for its vertically integrated R&D and manufacturing.
FINANCIAL SUMMARY (HKD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.5B | 3.3B | 3.5B | 4.0B | 4.4% | 4.6B | 5.1B | 5.9B | 22.1% |
| EPS (HKD) | 13.13 | 11.27 | 13.89 | 16.60 | 8.1% | 2.27 | — | — | — |
| Shares | 27.0M | 27.0M | 27.0M | 27.0M | 0.0% | 27.0M | — | — | — |
| Debt | 546.4M | 751.3M | 1.1B | 968.6M | 21.0% | 1.0B | — | — | — |
| Equity | 5.9B | 5.7B | 5.6B | 5.7B | -1.0% | — | — | — | — |
| Op CF | 116.0M | 461.7M | 777.8M | 815.7M | 91.6% | 710.1M | — | — | — |
| Inv CF | -629.7M | -53.5M | -857.0M | -80.9M | — | — | — | — | — |
| Fin CF | -151.2M | -325.5M | -274.6M | -549.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 1187.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 1187.HK | Cofoe Medical Technology Co.,Ltd.(you) | $913M | 92 | Strong Buy |
| 603387.SS | Getein Biotech, Inc | $742M | 93 | Strong Buy |
| 2190.HK | Zylox-Tonbridge Medical Technology Co., Ltd. | $875M | 82 | Strong Buy |
| 1789.HK | AK Medical Holdings Limited | $649M | 97 | Strong Buy |
| 2291.HK | LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. | $520M | 90 | Strong Buy |
| 688410.SS | SWS Hemodialysis Care Co., Ltd. | $651M | 86 | Strong Buy |
| 300206.SZ | Edan Instruments, Inc. | $1.0B | 76 | Buy |
| 600587.SS | Shinva Medical Instrument Co.,Ltd. | $1.2B | 79 | Buy |
| 1858.HK | Beijing Chunlizhengda Medical Instruments Co., Ltd. | $378M | 87 | Strong Buy |
| 2172.HK | MicroPort NeuroScientific Corporation | $584M | 78 | Buy |
Peer medians: ROE 4.3% · P/E 27.9x · Gross margin 52.6%
Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.